The impact of using hepatitis c virus nucleic acid test –positive donor hearts on heart transplant waitlist time and transplant rate

Previous studies suggest that direct-acting anti-virals (DAAs) for the treatment of hepatitis C virus (HCV) infection permits the transplantation of HCV-viremic donor organs in uninfected recipients. This opportunity may expand the donor pool. We assessed the impact of using HCV nucleic acid test –positive (NAT+) donor hearts on heart transplant (HTx) waitlist time and transplant rate.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: ORIGINAL CLINICAL SCIENCE Source Type: research